Guideline on the requirements for quality documentation ...

that may impair patients’ safety (e.g. microbiological aspects, viral contamination, dose). Due to the diversity of products to be used in the different phases of clinical trials, the requirements defined in this guideline can only be taken as illustrative and are not presented as an exhaust ive list.

  Microbiological